SciClone Pharmaceuticals
SciClone profit up 4.3% to RMB622.7m in H1 2021
SciClone profit up 4.3% to RMB622.7m in H1 2021
Its revenue rose 14.7% to RMB1.3b in the same period.
Most Read
1. Diagnostics M&A activity to stay subdued in H2 amidst tariff uncertainty 2. Raffles Medical Group names new Chief Technology Officer 3. Australia unveils new rules to support incoming Aged Care Act 4. 7MM hidradenitis suppurativa market to quadruple by 2034 5. Medical device market on track for mid-single digit growthResource Center
Read Here
Advertise
Sign Up
Event News
The medical institution earned recognition for its National Hospital Apps which have brought digital revolution in healthcare.
Commentary
The shift towards cognitive healthcare platforms leveraging AI, IoT, and Blockchain